What companies are RARE's competitors?

Ultragenyx Pharmaceutical Inc. (RARE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does RARE compare to its peers?

The peer comparison table on this page shows Ultragenyx Pharmaceutical Inc. (RARE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does RARE operate in?

Ultragenyx Pharmaceutical Inc. (RARE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQ·Biotechnology · Healthcare

$17.21$0.46+2.72%

Market cap$1.70B·Oct 28 11:03 AM EDT

Frequently Asked Questions About RARE

What companies are RARE's competitors?: Ultragenyx Pharmaceutical Inc. (RARE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RARE compare to its peers?: The peer comparison table on this page shows Ultragenyx Pharmaceutical Inc. (RARE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RARE operate in?: Ultragenyx Pharmaceutical Inc. (RARE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

RARE

Ultragenyx Pharmaceutical Inc.

NASDAQ·Biotechnology · Healthcare

$17.21$0.46+2.72%

Market cap$1.70B·Oct 28 11:03 AM EDT

Peers

Sort:


BBIOBBIOBridgeBio Pharma, Inc.	BridgeBio Pharma, Inc.	$69.52	$13.6B
BMRNBMRNBioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.	$55.99	$10.8B
PTCTPTCTPTC Therapeutics, Inc.	PTC Therapeutics, Inc.	$62.29	$5.2B
QUREQUREuniQure N.V.	uniQure N.V.	$25.01	$1.7B
MGTXMGTXMeiraGTx Holdings plc	MeiraGTx Holdings plc	$9.48	$910.0M
FDMTFDMT4D Molecular Therapeutics, Inc.	4D Molecular Therapeutics, Inc.	$12.14	$670.7M
RGNXRGNXREGENXBIO Inc.	REGENXBIO Inc.	$6.78	$447.6M
RCKTRCKTRocket Pharmaceuticals, Inc.	Rocket Pharmaceuticals, Inc.	$2.51	$275.0M
ABEOABEOAbeona Therapeutics Inc.	Abeona Therapeutics Inc.	$4.49	$256.5M
MREOMREOMereo BioPharma Group plc	Mereo BioPharma Group plc	$0.29	$47.0M

Frequently Asked Questions About RARE

What companies are RARE's competitors?: Ultragenyx Pharmaceutical Inc. (RARE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does RARE compare to its peers?: The peer comparison table on this page shows Ultragenyx Pharmaceutical Inc. (RARE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does RARE operate in?: Ultragenyx Pharmaceutical Inc. (RARE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.